Results 251 to 260 of about 254,139 (337)

A case of lactobezoar: Outpatient management in a neonate

open access: yesJPGN Reports, EarlyView.
Abstract A lactobezoar is a conglomerate of undigested and partially digested milk components and is the most common form of bezoar in infants. Described treatments include hospitalization for intravenous fluids and cessation of feeds, endoscopy with administration of N‐acetyl cysteine, and surgical or endoscopic removal.
Shivani Kamal   +3 more
wiley   +1 more source

Complex genomic rearrangements of the Y chromosome in a premature infant. [PDF]

open access: yesMol Cytogenet
Balow SA   +6 more
europepmc   +1 more source

Multicenter study of continuing ustekinumab after intravenous induction reactions in pediatric Crohn's disease

open access: yesJPGN Reports, EarlyView.
ABSTRACT Reactions to intravenous ustekinumab for inflammatory bowel disease (IBD) occur, the frequency of which is uncertain. It is unclear how often subcutaneous treatment is continued after reactions to the intravenous dose, or how well it is tolerated.
Joann Samalik   +16 more
wiley   +1 more source

International Contrast Ultrasound Society Safety Round Table

open access: yesJournal of Ultrasound in Medicine, EarlyView.
The international Contract Ultrasound Society (ICUS) held a round table discussion on the safety of ultrasound contrast agents for cardiology, radiology, and pediatrics on September 4, 2024. The panel included international experts on ultrasound contrast.
Richard G. Barr   +5 more
wiley   +1 more source

The Efficacy and Safety of Atenolol for Treatment of Infantile Hemangioma

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Infantile hemangiomas are the most common benign vascular tumours in children. Since the discovery of propranolol for infantile hemangiomas, its increasing side effect profile has prompted research into its beta‐1‐selective counterpart, atenolol.
Michelle Shi   +3 more
wiley   +1 more source

First Report of Homozygous COL7A1 c.5756delG Mutation Causing Recessive Dystrophic Epidermolysis Bullosa in a Non‐Consanguineous Japanese Family

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Severe recessive dystrophic epidermolysis bullosa (RDEB) is usually caused by biallelic loss‐of‐function mutations in COL7A1. While the c.5756delG variant has been previously reported in heterozygous form, its clinical impact in homozygosity has not been described.
Nozomi Kohama   +6 more
wiley   +1 more source

Trametinib restores the central conducting lymphatic flow in a premature infant with Noonan syndrome. [PDF]

open access: yesClin Case Rep
Leenders EKSM   +5 more
europepmc   +1 more source

Alternative Pathway of Complement Activation in Full Term and Premature Infants

open access: bronze, 1979
Robert C. Strunk   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy